Table 2.
Clinical presentation | Patients with DF without bleeding (n = 33) | Patients with DF with bleeding (n = 26) | P |
---|---|---|---|
Days with symptoms, median (range) |
7 (5–10) |
7 (2–15) |
0.68 |
Days in the hospital, median (range) |
0 |
2 (1–10) |
N.A. |
Fever |
33 (100) |
26 (100) |
N.A. |
Headache |
17 (51.5) |
22 (84,6) |
0.01 |
Prostration |
20 (60.6) |
24 (92,3) |
0.006 |
Nausea or Vomiting, n (%) |
11 (33.3) |
13 (50) |
0.28 |
Abdominal pain, n (%) |
3 (9) |
12 (46) |
0.002 |
Liver enlargement, n (%) |
0 |
2 (7.7) |
N.A. |
Hypotension, n (%) |
0 |
2 (7.7) |
N.A. |
Syncope, n (%) |
0 |
2 (7.7) |
N.A. |
Acute renal insuficiency, n (%) |
0 |
1 (3.8) |
N.A. |
Signs of plasma leakage, n (%) |
0 |
0 |
N.A. |
Shock, n (%) | 0 | 0 | N.A. |
N.A. = not aplicable.
This table shows patients’ symptoms and signs of dengue at the first clinical evaluation or during the follow-up.